The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data-Reference-Cited by-同舟云学术

The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data

Published:2023-01 Issue:1 Volume:26 Page:91-98
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Schöttler Marcel H.,Coerts Friso B.,Postma Maarten J.,Boersma Cornelis,Rozenbaum Mark H.

Funder

Pfizer BV

Pfizer

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference27 articles.

1. Consolidated health economic evaluation reporting standards (CHEERS)-explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force;Husereau;Value Health,2013

2. Guide to the methods of technology appraisal. The National Institute for Health and Care. https://www.nice.org.uk/process/pmg9/chapter/foreword. Accessed October 6, 2021.

3. The impact of patent expiry on drug prices: a systematic literature review;Vondeling;Appl Health Econ Health Policy,2018

4. Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis;Hoyle;Pharmacoeconomics,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions;Value in Health;2024-07

2. Impact of Incorporating Future Mandatory Price Reductions with Generic Drug Entry on the Cost-Effectiveness of New Drugs: A Policy Simulation Study of Dupilumab in Atopic Dermatitis Treatment;Healthcare;2024-05-02

3. Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis;2024-02-28

4. The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets;Journal of Health Economics;2023-07

5. The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics;Value in Health;2023-03